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Medium Term Survival of Pediatric Anterior Cruciate Ligament Reconstruction with Living 1 
Donor Hamstring Tendon Graft 2 
ABSTRACT 3 
Background:  4 
It is well accepted that there is a higher incidence of repeat Anterior Cruciate Ligament (ACL) injury in the 5 
pediatric population following ACL reconstruction (ACLR) with autograft tissue compared to adults. Hamstring 6 
autograft harvest may contribute to the risk for repeat ACL injury in this high functional demand group. A 7 
novel method is the use of a living donor hamstring tendon (LDHT) graft from a parent; however, there is 8 
currently limited research on the outcomes of this technique, particularly beyond the short-term.  9 
Purpose/Hypothesis: To determine the medium-term survival of the ACL graft and the contralateral ACL 10 
(CACL) after primary ACLR with the use of a LDHT graft from a parent in those aged less than 18 years, and to 11 
identify factors associated with subsequent ACL injury. It is hypothesised that ACLR with the use of a LDHT 12 
provides acceptable midterm outcomes in pediatric patients. 13 
Study Design: Case series; Level of evidence, 4. 14 
Methods: Between 2005 and 2014, 247 (out of 265 eligible) consecutive patients in a prospective database 15 
having undergone primary ACLR with the use of a LDHT graft aged less than 18 years were included. Outcomes 16 
were assessed at a minimum of two years following surgery including collection of data on ACL re-injury, 17 
International Knee Documentation Committee (IKDC) questionnaire, current symptoms and factors associated 18 
with ACL re-injury risk were investigated.  19 
Results: Patients were reviewed at a mean of 4.5 years (range 24-127 months (10.6years)) after ACLR with 20 
LDHT graft. Fifty one patients (20.6%) sustained an ACL graft rupture, 28 patients (11.3%) sustained a CACL 21 
rupture, and two patients sustained both an ACL graft and a CACL rupture (0.8%). Survival of the ACL graft was 22 
89%, 82% and 76% at 1, 2 and 5 years, respectively. Survival of the CACL was 99%, 94% and 86% at 1, 2 and 5 23 
years respectively. Survival of the ACL graft was favourable in those who were Tanner 1 and 2 stage of 24 
development at the time of surgery versus Tanner stage 3-5 at 5 years (87% versus 69%, hazard ratio 3.7, 25 
p=0.01).  26 
Conclusion: After ACLR with a LDHT graft from a parent in those aged less than 18 years, second ACL injury 27 
(ACL graft or CACL injury) occurred to 1 in 3 patients. The 5-year survival of the ACL graft was 76% and the 28 
CACL 5-year survival was 86%. High IKDC scores and continued participation in sports were maintained over 29 
the medium-term. Importantly, there was a favorable survival of the ACL graft in Tanner 1-2 patients 30 
compared with Tanner 3-5 patients over 5 years. Tanner 1-2 patients also had a significantly lower incidence of 31 
second ACL injury over 5 years compared to Tanner 3-5, occurring in 1 in 5 patients. Thus, the LDHT graft from 32 
a parent is an appropriate graft for physically immature children.  33 
Keywords: graft rupture; juvenile; adolescent; pediatric; contralateral ACL; survivorship; medium-term. 34 
What is known about the subject: Pediatrics are more likely to have a second ACL injury after ACLR compared 35 
to adults, utilizing a hamstring tendon autograft. There is no literature on the incidence of re-injury in the 36 
pediatric population with the use of hamstring tendon graft from a parent.  37 
What this study adds to existing knowledge: This study documents the medium-term incidence of ACL graft 38 
and CACL injury after ACLR in a large pediatric population with LDHT graft from a parent. Immature patients 39 
(Tanner 1 and 2) had better outcomes than those at Tanner stages 3-5. 40 
INTRODUCTION 41 
It has been advocated that a non-operative approach to ACL injury for pediatric patients is to avoid iatrogenic 42 
physeal disturbance.  There is evidence that non-operative treatment can lead to intra-articular pathology and 43 
poorer functional outcomes, particularly return to sport, when compared to operative management 2, 19, 30. 44 
However, high level evidence on the outcomes following both non-operative and operative management for 45 
the pediatric ACL is lacking.31. In recent years there has been increasing success and acceptance of operative 46 
management for ACL injury in the pediatric population as it may protect their menisci and articular cartilage 47 
from the classic pattern of injury seen in ACL deficiency, and can be performed without causing growth 48 
disturbance 6, 39.   49 
The incidence of ACL injury in pediatric patients is increasing 35, likely due to increased sports participation, 50 
earlier sports specialization and the increased recognition of ACL injuries 24. Furthermore, if the graft is injured 51 
requiring revision ACLR, there is an association with poorer outcomes compared to primary ACLR3, 52. A recent 52 
systematic review from Wiggins et al. 51 reported that athletes younger than 25 years of age, who return to 53 
sport, have a 23% incidence of second ACL injury over 4.25 years (pooled mean). Morgan et al. 32 examined 54 
patients 18 years or younger and reported a 31% incidence of second ACL injury over 15 years. These high 55 
rates of reinjury have led some surgeons to consider alternative graft options for pediatric patients.  56 
The influence of graft selection on the high rates of ACL re-injury in the pediatric population is poorly 57 
understood and numerous alternative graft options have been investigated 25, 41.  Whilst autograft is a graft of 58 
choice for ACLR, the key drawback is donor site morbidity. Patella tendon harvest is associated with anterior 59 
knee pain, reduced knee extension strength 37 and an inability to kneel 18. Similarly, hamstring tendon 60 
autograft harvest is associated with persisting hamstring strength deficit which may adversely affect walking 61 
and running 1, 34. Furthermore, the hamstring tendons can be under-developed in the pediatric population, 62 
leading to a small graft diameter for reconstruction 8.  63 
To eliminate donor site morbidity and muscular deficit secondary to graft harvest, allograft tendons can be 64 
used for ACLR. Allograft tissue was initially sterilised by irradiation, which alters the structural properties of the 65 
collagen. Some evidence suggests that cadaveric allografts are associated with higher rates of graft rupture 66 
compared to autografts in both pediatric and adult cohorts 14, 15, 26. It is unclear if this is related to the graft 67 
processing techniques. The LDHT graft from a parent, which is not frozen, irradiated or chemically treated, 68 
provides an alternative graft choice that is similar to traditional allograft tissue, allows for flexibility in graft size 69 
and avoids donor site morbidity. The graft size is particularly pertinent as there is an association between small 70 
graft diameter and ACL reinjury 23. Furthermore, it has been shown that soft tissue graft size is related to 71 
height and weight and that the ACL graft in the very young increases in length but does not increase in 72 
diameter9, 10, 49.  Utilising a donor graft from a physically larger parent with mature hamstring tendons enables 73 
a predictable graft diameter, which may reduce failure rates.  The use of allograft (including LDHT) also allows 74 
preservation of the hamstrings and use for potential revision cases in later life.  Cadaveric allograft tissue has 75 
been utilised in young patients where some authors have highlighted potential for disease transmission and 76 
immune reactions with this graft choice 4, 25. This can be more reliably screened in parental donors.  77 
Conversely, there are unique considerations that may not favour the use of LDHT graft in the pediatric 78 
population. Firstly, LDHT harvest adds surgical morbidity to a secondary party, who are typically older and have 79 
a poorer anaesthetic risk profile. Goddard et al. 16 (2013) found that 28 out of the 29 parental donors for 80 
juvenile ACLR reported no complications and would undergo the same procedure again if required. Secondly, 81 
the cost associated with the procedure is greater than the traditional autograft method 16. However, any 82 
significant reduction in ACLR reinjury rate would greatly improve the overall burden on the patient and health 83 
care system.  84 
Only two previous studies have examined outcomes of ACLR after LDHT graft from a parent, but the cohorts in 85 
these studies were small and restricted to two year follow-up16, 17. As such, there is currently no evidence on 86 
the medium-term incidence of ACL re-injury with the use of LDHT graft. The aim of this study is to determine 87 
the medium-term survival of ACLR with LDHT graft, and incidence of CACL rupture, and to identify the factors 88 
that affect LDHT and CACL survival in a pediatric population post primary ACLR.  89 
MATERIALS AND METHODS 90 
Patient Selection 91 
Patients included in the study were identified from a prospective database of knee surgery and had undergone 92 
a primary ACLR with LDHT graft at least 2 years earlier.  The participant flow is detailed in Figure 1. Patient 93 
demographics were recorded in a prospective database which included information on the side of surgery, 94 
age, gender, Tanner stage, physeal status, graft donor source, graft size and meniscal or articular cartilage 95 
injury. Patients were sent an information sheet via post or email providing details of the project and inviting 96 
them to participate.  Subjective outcome data were obtained by contacting all patients meeting the inclusion 97 
criteria via telephone or email.  Those willing to participate in the study completed a telephone interview or 98 
written questionnaire, which was returned via post or email.  A research physiotherapist or an honours 99 
medical student, both of whom had not been involved in the original surgery, performed the telephone 100 
questionnaires. Ethical approval was granted by a local independent human ethics committee.  101 
 102 
Figure 1: Participant Flow Chart 103 
Subjective Evaluation 104 
The questionnaire completed by patients included the full IKDC subjective knee evaluation form in addition to 105 
questions relating to family history of ACL rupture, subsequent injury and/or surgery to either knee, whether 106 
return to pre-injury level of sport was achieved and the current level of activity of the patient.  Family history 107 
was considered to be positive if the patient reported that a first degree relative (parents or sibling/s) had 108 
sustained an ACL rupture at any time.  A return to IKDC level 5 sports was defined as regular participation in 109 
very strenuous activities involving cutting or pivoting type manoeuvres, as in basketball or soccer. 110 
All patients who reported further injury to either knee that had not previously been documented were invited 111 
to attend for further review. Graft rupture or CACL rupture was considered to have occurred only if one of the 112 
following was present: (1) the patient had further knee reconstructive surgery (graft rupture) or primary 113 
reconstruction (CACL) performed in our unit or by another orthopaedic surgeon; (2) had clinical examination 114 
and/or an MRI scan reviewed by our unit to confirm ACL deficiency, (3) had reported another injury 115 
characteristic of an ACL tear to either knee that had not been reviewed by us. For this last group, it was 116 
assumed an ACL graft rupture or CACL rupture for the purposes of the survival analysis as a worst-case 117 
scenario.  118 
Operative Technique 119 
ACLR was performed by one of two specialist knee surgeons (L.A.P and J.R) in a single unit between the years 120 
of 2005 and 2014. All patients and donors underwent preoperative blood testing including human 121 
immodeficiency virus (HIV), hepatitis B and C, human papillomavirus (HPV), cytomegalovirus (CMV) and 122 
syphilis testing. All patients underwent blood group testing including Rh status. Any Rh-negative female 123 
patients were given the appropriate dose of Rh immunoglobulin on induction of anaesthesia to prevent 124 
potential Rh sensitization.  125 
 126 
Two fully staffed adjacent operating theaters were used and surgery was performed as day cases. In one 127 
theatre, the gracilis and semitendinosus tendons were harvested from the parent donor. A tendon harvester 128 
(Linvatec, Largo, Florida) was used to obtain a 22-cm tendon graft. Graft size was determined in regard to the 129 
ACL footprint, to ensure a graft of adequate diameter but not one that would cause impingement at the 130 
intercondylar notch. The tendons were wrapped securely in vancomycin soaked gauze and taken by the 131 
surgeon to the adjacent operating theater. In the second operating theater, the child was already under 132 
anesthesia and prepared and draped for surgery. Endoscopic transphyseal anatomic single-tunnel ACLR was 133 
performed. The operative technique has been previously described in detail 16, 17.  134 
 135 
From the 247 patients reviewed, there was 1 one-stranded, 30 two-stranded, 18 three-stranded, 191 four-136 
stranded, 6 five-stranded and 1 six-stranded LDHTs utilised. Femoral fixation included the round-headed Ti 137 
cannulated interference screw (n = 167) (RCI, Smith & Nephew, Andover, Massachusetts), Endobutton (n = 49) 138 
(Smith & Nephew), round-headed cannulated interference PEEK RCI screw (n = 29) (Signature Orthopaedics) 139 
and staple (n = 2). Tibial fixation included the Ti RCI screw (n = 150) (Smith & Nephew), staple (n = 56), PEEK 140 
RCI screw (n = 35) (Signature Orthopaedics), BioRCI screw (n=5) (Smith & Nephew), and post fixation (n = 1). 141 
Routine radiographs were obtained postoperatively. Patients were allowed to bear full weight, and 142 
commenced an early accelerated rehabilitation program 46.  At 9 to 12 months, an objective assessment of 143 
rehabilitation goals was performed to assess readiness to return to competitive sports, especially those that 144 
involved pivoting or side-stepping activity. Growth plate status was assessed from the immediate post 145 
operative x-ray. Patients with open physes at the time of surgery obtained an annual x-ray of the knee. A long 146 
leg alignment x-ray was also obtained at two years post operation, and then at 18 years of age. The long leg 147 
alignment x-ray was assessed by the treating surgeon for growth disturbance or leg length discrepancy.  148 
 149 
Statistical Analysis 150 
Statistical analysis was performed using SPSS software. Statistical significance was set a priori at p ≤0.05. 151 
Groups were compared with t-tests for linear variables (mean IKDC scores) and chi square tests for categorical 152 
data (gender, age, family history, growth plate status and Tanner stage). 153 
The probability of failure (ACL graft rupture and/or CACL injury as well as second ACL injury) was estimated as 154 
a function of time using the Kaplan-Meier (K-M) survival method. Survival tables at 1, 2 and 5 years were 155 
collated.  Comparisons of survival curves were made with univariate Cox proportional hazards. Factors 156 
examined included age, sex, family history of ACL injury, growth plate status and Tanner score. Factors with p 157 
≤0.10 on univariate analysis were entered into a multivariate Cox regression analysis. Factors were then 158 
eliminated in a stepwise fashion, until only the independent significant factors remained. Multiple imputation 159 
was utilised for Tanner score to account for missing cases in the analysis by using the variables age and growth 160 
plate status. Imputated and non-imputated raw Tanner data provided the same statistical significance for the 161 
analysis. Non-imputated raw Tanner data are presented in the results section. Analysis was performed on the 162 
whole group, and repeated for each gender independently.    163 
RESULTS  164 
Between January 2005 and December 2014, 5,364 patients underwent primary ACLR. Of these, 265 patients 165 
were under 18 years of age, and in these cases a LDHT graft was harvested, thus forming the study cohort. 166 
There were 247 (93%) patients that completed the subjective questionnaire at a mean of 4.5 years after 167 
surgery (range 24 months – 127 months (10.6 years)). The participant flow is shown in Figure 1. Of the 247 168 
patients, 166 (67%) had no subsequent ACL injuries and 81 (33%) sustained a further ACL injury. Of the 169 
patients who sustained further ACL injuries, 51 patients (20.6%) sustained an ACL graft rupture, 28 patients 170 
(11.3%) sustained a CACL injury and 2 patients (0.8%) sustained both an ACL graft and a CACL rupture.  171 
Demographics (n=247) 172 
There were 82 (33.2%) females and 165 (66.8%) males.  The mean age at surgery was 14.6 years (range, 8-173 
17.9). There were 128 left-sided and 119 right-sided reconstructions.  Surgery was performed in the acute 174 
phase (within 3 weeks of injury) in 7 patients (2.7%), in the sub-acute phase (3-12 weeks) in 201 patients 175 
(81.4%) and in the chronic phase (> 12 weeks) in 39 patients (15.8%). Tanner stage of development was 176 
collected in a prospective manner at the time of surgery for 202 of the 247 patients. There were 23 Tanner 1, 177 
24 Tanner 2, 29 Tanner 3, 79 Tanner 4 and 47 Tanner 5 patients (Figure 2). LDHT graft was obtained from the 178 
father in 201 patients (81.4%) and the mother in 42 patients (17%). One step-father, one uncle, one brother 179 
and one sister also donated a LDHT graft (.4%). The mean diameter of the LDHT graft was 7.5mm (range 4.5-180 
8.5mm). 153 patients (62%) had an isolated ACLR, without meniscal surgery.  At the time of surgery, 12 181 
patients (4.8%) required partial medial meniscectomy and 46 patients (18.6%) required partial lateral 182 
meniscectomy.  Meniscal sutures were used in 10 patients (4%) in the medial meniscus and 26 patients 183 
(10.5%) in the lateral meniscus. The primary ACL rupture was most commonly sustained in the sports of rugby 184 
and soccer, which accounted for 59% of injuries (see Figure 3).  185 
 186 
Figure 2: Tanner score at time of surgery in 202 of the 247 patients reviewed 187 
 188 
Figure 3: Sport of the primary ACL injury 189 
Subjective Outcomes 190 
Of the 247 patients with an intact ACL graft who completed the questionnaire, 146 (59.1%) reported returning 191 
to their pre-injury level of activity.  Of the 101 who did not return to the pre-injury level of activity, 37 (15%) 192 
reported it was due to their operated knee and the remaining 64 patients (25.9%) cited other reasons. The 193 
mean overall IKDC score was 91.7 (range, 57-100).  There was no significant difference between the mean 194 
subjective IKDC score between males and females (92.4 v 90.4, p=.25).  There was no significant difference in 195 
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the mean IKDC score between Tanner 1 and 2 patients versus Tanner 3-5 patients (92.3 v 91.9, p=.78), closed 196 
versus open growth plates (92.3 v 90.4, p=.17), or age < 14 or more versus ≥ 14 years (91.6 v 92.1, p=.72).  197 
Incidence of Second ACL injury (ACL graft or CACL injury)  198 
The incidence of ACLR graft injury was significantly higher than the incidence of CACL injury after 199 
reconstruction (p=0.006). Tanner 3-5 patients had a significantly higher incidence of a second ACL injury 200 
(38.1%) compared to Tanner 1 and 2 patients (21.3%) (p=0.03). There was a trend for patients aged 14 years or 201 
more to have a higher incidence of second ACL injury compared to those less than 14 years of age (36.1% 202 
versus 23.9% respectively; p=0.07). A positive family history was associated with a significantly higher 203 
incidence of second ACL injury than patients without a positive family history (34.2% vs. 21.3%, p=0.04). There 204 
was no significant difference in the incidence of second ACL injury between genders or growth plate status 205 
(p=0.59 and p=0.46 respectively). A summary of second ACL injury can be seen in Table 1. 206 
TABLE 1 – Incidence of Second ACL Injury according to selected variables (ACL graft or CACL Injury)  207 
Variable No. of patients ACL Graft or CACL 
Injury  
% ACL Graft/CACL 
Injury  
p value 
Age at surgery, y  
< 14 67 16  23.9% .07 
≥ 14 180 65  36.1% 
Sex 
Male 165 56  33.9% .59 
Female 82 25  30.5% 
Family History of ACL injury 
Yes 76 26  34.2% .04 
No 141 30  21.3% 
Growth Plate Status  
Open 83 25  30.1% .46 
Closed 155 54  34.8% 
Tanner Stage  
1-2 47 10  21.3% .03 
3-5 155 59  38.1% 
Bolded p value indicates statistical significance (P ≤ .05). ACL, anterior cruciate ligament  208 
ACL Graft Rupture 209 
ACL graft rupture occurred in 53 (21.5%) patients (inclusive of the two patients that ruptured both their ACL 210 
graft and CACL) at a mean follow up of 4.5 years post ACLR. ACL graft injury occurred at a mean of 17.5 months 211 
(range 1.5 – 60) post primary ACLR.  One male patient reported a knee injury associated with instability but 212 
was unable to attend for review; he was assumed to have sustained an ACL graft rupture. Patients who 213 
reported characteristics of rupture in the questionnaire and had not undergone further reconstructive surgery 214 
were examined in our unit to confirm ACL stability. All ACL ruptures occurred during sport and recreational 215 
activities and soccer was the sport that accounted for the most ACL graft ruptures which can be seen in Table 216 
2.  217 
TABLE 2 – Sports Associated with ACL Graft Rupture  218 
Sport No. of patients with ACL graft 
rupture (n=51) 
Mean months to ACL failure 
Soccer 18 21.6 
Rugby or Australian Rules Football 15 22 
Netball 3 11 
Basketball 3 11.7 
Playing at School 2 8 
Fall/Jumping Fence 3 24 
Dance 1 24 
High Jump 1 10 
Motorbike  1 16 
Bicycle  1 13 
Tee ball 1 4 
Surfing 1 9 
Skateboard  1 4 
  219 
The ACL graft rupture was confirmed at the time of revision ACL surgery in 44 patients and by MRI and clinical 220 
examination in nine patients. Kaplan-Meier survival analysis for ACL graft rupture is shown in Figure 4 (A).  ACL 221 
graft survival was 89%, 82% and 76% at 1, 2 and 5 years post reconstruction, respectively.  The results of 222 
univariate analysis are shown in Table 3.  Tanner score and age at surgery were entered into a multivariate Cox 223 
regression analysis and missing Tanner variables were accounted for with multiple imputation. On stepwise 224 
analysis, only Tanner Stage 3-5 remained significantly associated with poorer ACL graft survival with a hazard 225 
ratio of 3.7 (95% CI 1.34 – 10.39, p=0.01) (Multiple imputation data set hazard ratio of 3.0 (95% CI 2.06 – 4.54, 226 
p=<0.001).  The Kaplan-Meier chart of ACL graft survival and Tanner Stage is shown in Figure 4 (B).  227 
  228 
 229 
Figure 4: (A) Survivorship analysis of the ACL graft over time.  (B) Survivorship analysis of the ACL graft in 230 
relation to Tanner Stage, p=.01. 231 
TABLE 3 - Survival of the ACL Graft with Univariate Hazard Ratios for the Examined Patients (N = 247 232 
Patients) 233 
Variable No. of 
patients 
1 year 
survival (%) 
2 year 
survival (%) 
5 year 
survival (%) 
Hazard Ratio 
(95% CI) 
p value 
All Patients 51/247 
(20.6%) 
89 82 76 - - 
Age at surgery, y 
< 14 67 96 90 84 1.9 (.94 – 
3.94) 
.07 
≥ 14 180 87 78 73 
Sex  
M 165 88 80 73 1.4 (.78 – 
2.65) 
.24 
F 82 91 84 82 
Family History of ACL injury 
Yes  93 87 81 1.5 (.72 – 
3.10) 
.29 
No  94 90 87 
Growth Plate Status 
Open 155 88 84 79 1.2 (.68 – 2.19 
.51 Closed 83 90 80 72 
Tanner Stage  
1-2 47 98 95 87 3.7 (1.34 – 
10.39) 
.01 
3-5 155 84 74 69   
Graft diameter 
≤7mm 69 93 85 83 1.5 (.78 – 
2.83) 
.23 
>7mm 178 88 80 73 
Femoral Fixation 
Screw 194 89 80 74 .63 (.28 – 
1.39) 
 .25 
Endobutton 51 92 87 83 
Living Donor Hamstring Tendon  
Female 
Donor 
43 79 74 74 1.3 (.69-2.6) .39 
Male Donor  205 96 91 83 
 234 
Contralateral ACL Injury 235 
32 patients (12.9%) sustained a CACL rupture during the study period (inclusive of the two patients that 236 
ruptured their ACL graft and CACL). CACL injury was confirmed at the time of CACL reconstruction in 30 237 
patients, and clinical examination and MRI in our unit in 2 patients.  CACL injury occurred at a mean of 37 238 
months (range, 6-84) post primary ACLR (Figure 5A).  CACL survival was 99%, 94% and 86% at 1, 2 and 5 years 239 
respectively, post reconstruction.  The results of univariate analysis are shown in Table 4. CACL survival was 240 
not significantly associated with age, growth plate status, Tanner stage, graft diameter or femoral fixation.  241 
Patients who had a positive family history of ACL injury displayed a non-significant trend to poorer CACL 242 
survival compared to those without a positive family history (p=.09) (Figure 5B).  243 
 244 
  245 
Figure 5: Survivorship analysis of the CACL over time.  (B) Survivorship analysis of CACL in relation to family 246 
history p=.09 247 
 248 
  249 
TABLE 4 250 
Survival of the contralateral ACL with univariate hazard ratios for the examined variables 251 
 (N = 247 Patients) 252 
Variable No. of 
patients 
1 year 
survival (%) 
2 year 
survival (%) 
5 year 
survival (%) 
Hazard Ratio 
(95% CI) 
p value 
All patients 28/247 
(11.3%) 
99 94 86 - - 
Age at surgery, y 
< 14 67 96 90 84 1.3 (.57 – 
3.13) 
.51 
≥ 14 180 87 78 73 
Sex  
M 165 99 94 87 .89 (.42 – 
1.87) 
.76 
F 82 97 95 82 
Family History of ACL injury 
Yes 76 96 95 83 1.9 (.91 – 
3.99) 
.09 
No 141 87 94 87 
Growth Plate Status 
Open 83 98 95 90 1.1 (.51 – 
2.39 
.80 
Closed 155 99 94 82 
Tanner Stage  
1-2 47 98 93 93 1.1 (.45 – 
2.94) 
.78 
3-5 155 99 95 80 
Graft diameter 
≤7mm 69 99 92 86 1.0 (.47 – 
2.17) 
.99 
>7mm 178 99 95 85 
Femoral Fixation 
Screw 194 99 96 87 1.3 (.54 – 
3.27) 
.53 
Endobutton 51 96 89 86 
 253 
Gender Analysis  254 
14 (17.1%) females and 39 males (23.6%) had an ACL graft rupture; however, there was no significant 255 
difference between males and females in survival of the ACL graft or CACL at 5 years post surgery (p=.24 and 256 
p=.76 respectively; see Table 3 and 4). Eleven females (13.4%) and 19 males (11.5%) had a CACL injury.  In male 257 
patients, there was a significant association between ACL graft rupture with positive family history (p=0.01) 258 
and Tanner stage 3-5 (p=.01); there was also a non-significant trend toward graft rupture for patients aged less 259 
than 14 years (p=.06). When both genders were pooled, there was no significant association between the 260 
variables Tanner stage, age or growth plates status for ACL graft rupture or CACL injury (see Table 5(a) & 5(b)). 261 
TABLE 5a. Survival of the ACL graft with Univariate Hazard Ratios for the Examined Patients by Gender  262 
 Male Gender Female Gender 
Odds 
Ratio 
95% confidence 
interval 
P Odds 
Ratio 
95% confidence 
interval 
P 
Positive Family 
History 
2.95 1.3-6.9 .01 0.21 .0-11.1 .23 
Tanner Stage 3 or 
more 
3.53 1.2-9.9 .02 0.4 .0-68.7 .40 
Age 14 or more years .47 .2-1.9 .06 1.6 .36-7.2 .54 
Open Growth Plates .79 .4-1.5 .49 2.67 .35—20.5 .35 
 263 
Table 5b. Survival of the CACL with Univariate Hazard Ratios for the Examined Patients by Gender 264 
 Male Gender Female Gender 
Odds 
Ratio 
95% confidence 
interval 
P Odds 
Ratio 
95% confidence 
interval 
P 
Positive Family 
History 
2.27 .87-5.89 .09 1.3 .42-4.56 .59 
Tanner Stage 3 or 
more 
1.12 .40-3.38 .77 1.04 .12-8.70 .97 
Age 14 or more years .71 .25-7.98 .50 1.15 .25-5.34 .86 
Open Growth Plates .79 .32-2.00 .63 0.75 .16-3.52 .71 
 265 
Open Growth Plates  266 
There were no growth disturbances noted on x-ray or long leg alignment films by the treating surgeons at a 267 
mean of 37 months (range 5-102 months) post surgery in the 83 skeletally immature patients in this series.  268 
DISCUSSION 269 
The 5 year survival rate of the ACL graft and CACL post primary ACLR with the use of a LDHT graft was 76% and 270 
86% respectively. Survival of the ACL graft was favourable in those who were Tanner stage 1 and 2 at the time 271 
of surgery compared with Tanner 3-5 patients by a factor of 3.1.  The use of a LDHT graft for ACLR offers 272 
acceptable 5 year survival for skeletally immature patients. 273 
There is limited research on the use of a LDHT for ACLR other than those that have published from our group 274 
with a smaller sample size and shorter follow up than this current series.16, 17 Furthermore, there are few 275 
studies with a patient cohort as young as our current series and, to our knowledge, no large scale studies 276 
available on the medium-term outcome of ACLR with LDHT graft for comparison. Direct comparison of the 277 
cohort of living donor patients with traditional autograft patients is difficult due to the differences in the 278 
patient population and length of follow up in the published literature. In a previous study of patients 18 years 279 
or less with an ACLR performed at the same institution, utilising autologous hamstring tendon, ACL graft 280 
survival was 88% at five years and 83% at 15 years 32. However the population of this autograft series were 281 
older than our current series (mean age 16 years versus mean age of 14.6 years). If we compare the outcomes 282 
according to age, the five year ACL graft survival in those 14 or less was 84% with LDHT graft and 78% with 283 
hamstring tendon autograft. For those age >14 years ACL graft survival was 73% with the LDHT graft and 90% 284 
with the hamstring tendon autograft. Direct comparison of these two cohorts is limited by the consecutive 285 
nature of the series, particularly the effect of evolving rehabilitation protocols; however the two cohorts are 286 
from the same institution and involved the same surgeons. In the absence of a randomised series, our results 287 
suggest that the use of a LHDT graft may be considered reasonable in patients aged 14 year or less, but we 288 
cannot conclude that it reduces the incidence of graft rupture in adolescents when compared to a hamstring 289 
autograft.  290 
Lower second ACL injury in Tanner 1 and 2 pediatrics  291 
A lower rate of second ACL injury was noted in physically immature patients. Tanner 1 and 2 patients had a 292 
one in five incidence of second ACL injury compared with Tanner 3 – 5 patients who had just over a one in 293 
three incidence of second ACL injury (21.3% versus 38.1%) at a mean of 4.5 years post surgery. The reasons for 294 
this lower rate of re-injury in the immature patients may be multi-factorial. Socially, juveniles may be 295 
protected from second ACL injury compared with the adolescents due to increased parental supervision. 296 
Adolescents may have more freedom to play at a higher level, and participation in competitive sports is often 297 
more aggressive, which potentially increases their likelihood of re-injury. Furthermore, adolescents have a 298 
greater body mass as they grow, generating larger moments and greater inertia during sports. According to 299 
Barber-Westin et al. (2006)5 these factors highlight the need for continued neuromuscular control training 300 
throughout adolescence. In prepubescent patients, neuromuscular control issues may be offset by their lower 301 
body mass and reduced movement velocities5. Distinctive cellular responses may also contribute to the lower 302 
rate of secondary ACL injury in younger patients; animal studies in minipigs have suggested that there may be 303 
a faster healing response and increased cellularity in the skeletally immature ACL, compared to adults 27, 28. It 304 
has been demonstrated that fibroblasts from the ACLs of immature pigs and sheep grow faster and migrate 305 
faster than adolescent cells 28, 33; however equivalent human studies are currently lacking 22. It remains to be 306 
determined whether Tanner 1 and 2 patients will go on to have elevated risk once they move into 307 
adolescence. While the factors contributing to second injury are likely to be multifactorial and frequently 308 
theoretical, it can be concluded that the adolescents have the greatest risk of second ACL injury compared to 309 
both juveniles and adults.  310 
Patients with open growth plates  311 
There were no measurable growth disturbances or varus/valgus mal-alignment noted on radiographs in the 83 312 
skeletally immature patients in this series with open growth plates at a mean of 37 months post surgery (range 313 
5-102 months). This finding is consistent with the growing literature base confirming ACLR utilising a 314 
transphyseal approach as a safe procedure with no significant episodes of growth disturbance or varus/valgus 315 
alignment when carefully performed 11, 29, 40, 47. The surgical technique used in this series respects the 316 
important principles that only soft tissue grafts should be used, that the tibial and femoral tunnel diameter 317 
must be less than five percent of the physeal cross-sectional area, and that graft fixation is placed away from 318 
the open physis to avoid growth disturbance20, 38, 53.  319 
Gender differences 320 
In this series of patients, there was no significant difference between males and females in terms of survival of 321 
the ACL graft or CACL which is consistent with findings in the literature 42, 44, 48. Webster et al. 50 examined a 322 
series of patients younger than 20 years post ACLR with autologous hamstring grafts, and the subgroup of 323 
patients less than 18 years had a second ACL injury rate of 44.3% in males and 31.8% in females (our LDHT 324 
graft series 33.9% and 30.5% respectively) at 5 years. When analysing males independently, there was a 325 
statistically significant association between ACL graft rupture and a positive family history, and Tanner stage 3-326 
5 (compared with Tanner stage 1-2). These differences were not present in females. This could be due to 327 
differing cohort sizes in this series (165 males, 82 females). Further investigation into gender differences 328 
between sexes in the young is warranted.  329 
Gender of the LDHT graft also demonstrated no significant difference in terms of survival of the ACL graft at 5 330 
years (p=.39). However at 2 years, there was a 74% ACL graft survival in female living donor patients compared 331 
to 91% in male donors. The lack of statistical significance may be reflective of the smaller sample size of female 332 
versus male living donors (n=43 vs n=205). Further studies into the gender of living donors is warranted.  333 
 334 
Graft Selection  335 
Graft selection in ACLR is controversial. The ideal graft recreates the anatomical and biomechanical properties 336 
of the native ligament, provides rapid biological integration, reduces recovery time and donor site morbidity 12, 337 
21. Integration time of allograft versus autograft tissue is well documented in numerous animal studies 338 
involving goats, sheep, and rabbits for example 13, 36, 45. However, it is difficult to extrapolate animal data to 339 
humans directly. Nevertheless, there is support deeming that cadaveric allograft tissue is slower to incorporate 340 
than autograft 7, 20. This documented slower incorporation rate is unknown in the situation of the fresh graft 341 
harvest from a living donor. Further research into graft incorporation in the unique case of LDHT graft is 342 
required to know whether its incorporation rate is similar to an autograft.   343 
Study Limitations  344 
Due to the retrospective nature of the study design there was incomplete data that must be considered when 345 
interpreting results. Firstly, Tanner stage was collected in 202 of the 247 patients.  The missing data is due to 346 
the overlap period before our institution collected Tanner stage as a variable. The multiple imputation 347 
statistical technique was also utilised to account for the missing Tanner stage data and the findings continued 348 
to highlight a significant ACL graft survival difference between Tanner 1-2 and Tanner stage 3 or more. 349 
Secondly, family history was successfully obtained in 217 of the 247 patients so there is missing data for this 350 
variable that also needs to be considered.  351 
Furthermore, choice of soft tissue graft in ACLR remains debated 43, and in our cohort of patients a variety of 352 
femoral fixation devices were utilised including interference screw, endobutton and staple fixation. This 353 
variation in fixation highlights another weakness of the retrospective study design however caution was taken 354 
in all cases to ensure fixation was situated away from the physes in patients with open growth plates. Despite 355 
the studies weaknesses, the retrospective study design has allowed the collection of data on 247 patients that 356 
provides sufficient statistical power to investigate outcomes in a particular sub-cohort of patients with ACLR.  357 
Conclusions 358 
We present the largest pediatric series of all arthroscopic transphyseal single bundle ACLR with LDHT with 359 
follow up to a mean of 4.5 years post surgery. ACL injury after ACLR in juveniles and adolescents remains a 360 
challenging problem. ACLR using a LDHT graft is associated with good subjective outcomes. Tanner 1 and 2 361 
stage patients have a lower incidence of repeat ACL injury compared to adolescents. Thus, using a LDHT graft 362 
for ACLR may be an appropriate graft to consider for the skeletally immature. However, for those adolescents 363 
who are skeletally mature, we are unable to advocate the use of LDHT for ACLR.  364 
 365 
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